Notably, exosomal GC1 demonstrated an AUC score of 0.9022 in GC patients with negative CEA, CA 72-4, and CA19-9, highlighting its potential for early and effective screening of GC (95–97). This evidence concerns the gene CEACAM5 and gastric cancer.